Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland

Annals of Human Genetics
M KrześniakM Rusin

Abstract

Functional genetic polymorphisms of DNA repair genes are good candidates for cancer susceptibility markers. We studied two genes coding for proteins removing small DNA adducts by direct repair (MGMT), or mispaired DNA bases by base excision repair (TDG). The non-silent polymorphisms of MGMT (84:Phe, 143:Val, 178:Arg) and TDG (199:Ser, 367:Met), and the functional MGMT enhancer polymorphism, did not show any statistically significant association with lung cancer risk in our case-control analysis, but due to the relatively small number of individuals, strong conclusions on cancer risk association or lack thereof cannot be made. Sequencing of the TDG cDNA has not revealed any novel polymorphism, but did find an alternatively spliced mRNA missing exon 2. Our search for polymorphisms within the promoter-enhancer region of MGMT revealed three novel sequence variants. The functional significance of the previously published MGMT enhancer polymorphism (1099C->T) was assessed. The less frequent sequence variant of the enhancer was associated with a modest (16-64%), but statistically significant, increase of MGMT promoter-enhancer activity in the studied cell lines. This work points to the importance of studying the expression-regulating ...Continue Reading

References

Jan 1, 1995·Progress in Nucleic Acid Research and Molecular Biology·A E PeggR C Moschel
Nov 14, 1997·Science·F P Perera
Jun 9, 1999·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·T YatsuokaA Horii
Apr 18, 2000·Mutation Research·T R Waters, P F Swann
Apr 4, 2001·Carcinogenesis·D ButkiewiczC C Harris
Sep 18, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chikako KiyoharaJulian M Hopkin

❮ Previous
Next ❯

Citations

Mar 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuguang LengSteven A Belinsky
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeff A SloanPing Yang
Feb 21, 2014·Genetic Testing and Molecular Biomarkers·Cheng ChenShiwei Duan
Jan 7, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Zhi-xiong QiuPin-zhong Chen
Apr 24, 2014·International Journal of Molecular Sciences·Hee Nam KimHyeoung-Joon Kim
Dec 3, 2014·Pharmacological Reports : PR·Witold KyclerKatarzyna Lamperska
Dec 1, 2012·Mutation Research·Ashley B SjolundJoann B Sweasy
Sep 16, 2015·Acta Biochimica Et Biophysica Sinica·Xuehe XuChunming Liu
Nov 13, 2007·Biochemical Pharmacology·Qingming FangAnthony E Pegg
Jul 14, 2007·Molecular Aspects of Medicine·Barbara Tudek
May 8, 2007·DNA Repair·Anthony E PeggNatalia A Loktionova
Jun 16, 2007·DNA Repair·Andrew C PoveyMauro F Santibáñez-Koref
Apr 24, 2010·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Sung-Hsien HuangKan-Tai Hsia
Sep 25, 2010·Cellular & Molecular Biology Letters·Dorota ButkiewiczMarek Rusin
Jan 19, 2012·Cancer Letters·Susan S WallaceJoann B Sweasy
Sep 28, 2007·Neuroepidemiology·Martha J FeliniMargaret R Wrensch
Jun 17, 2016·Cellular Oncology (Dordrecht)·Meixiang XuSherif Z Abdel-Rahman
Jan 1, 2011·Cancers·Seon-Hee Yim, Yeun-Jun Chung
Oct 25, 2007·International Journal of Cancer. Journal International Du Cancer·Philip A J CrosbieAndrew C Povey
Dec 31, 2005·Molecular Carcinogenesis·Myung Hwa ChaeJae Yong Park
Jun 27, 2019·Journal of Oncology·Narasimha Reddy ParineMohammad Alanazi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.